The AI workspace for legal professionals
- Legal research with access to more than 1 million sources
- Document automation
- Matter management
- Hosted in the EU and Switzerland
Try it free for 14 days (10 questions/day during trial)
The AI workspace for legal professionals
Try it free for 14 days (10 questions/day during trial)
21-1926•Azurity Pharmaceuticals, Inc. v. Bionpharma Inc.
21-1926Court of Appeals for the Federal CircuitMar 9, 2022
NOTE: This disposition is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
AZURITY PHARMACEUTICALS, INC.,
Plaintiff-Appellant
v.
BIONPHARMA INC.,
Defendant-Appellee
______________________
2021-1926, 2021-1927
______________________
Appeals from the United States District Court for the
District of Delaware in Nos. 1:18-cv-01962-LPS, 1:19-
cv-01067-LPS, Judge Leonard P. Stark.
______________________
JUDGMENT
______________________
RICHARD TORCZON, Wilson, Sonsini, Goodrich & Rosati,
PC, Washington, DC, argued for plaintiff-appellant. Also
represented by TY WILLIAM CALLAHAN, GRANVILLE
CLAYTON KAUFMAN, Los Angeles, CA; WENDY L. DEVINE,
NICHOLAS SYLVESTER HALKOWSKI, KRISTINA M. HANSON,
San Francisco, CA; NATALIE J. MORGAN, San Diego, CA.
ANDREW M. ALUL, Taft, Stettinius & Hollister, LLP,
Chicago, IL, argued for defendant-appellee. Also repre-
sented by ROSHAN SHRESTHA.
Case: 21-1926 Document: 48 Page: 1 Filed: 03/09/2022
-- 1 of 2 --
______________________
T HIS CAUSE having been heard and considered, it is
O RDERED and ADJUDGED:
P ER CURIAM (N EWMAN, CLEVENGER , and STOLL , Cir-
cuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY O RDER OF THE COURT
March 9, 2022
Date
/s/ Peter R. Marksteiner
Peter R. Marksteiner
Clerk of Court
Case: 21-1926 Document: 48 Page: 2 Filed: 03/09/2022
-- 2 of 2 --
Connect Omnilex to search the legal corpus from your AI assistant.